(OSS) One Stop Systems - Overview
Stock: Rugged Servers, AI Edge Systems, GPU Accelerators, Flash Storage Arrays
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 141% |
| Relative Tail Risk | -23.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.25 |
| Alpha | 93.88 |
| Character TTM | |
|---|---|
| Beta | 1.486 |
| Beta Downside | 2.164 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.04% |
| CAGR/Max DD | 0.75 |
Description: OSS One Stop Systems January 20, 2026
One Stop Systems Inc. (NASDAQ: OSS) designs and manufactures rugged, high-performance compute, networking, and storage platforms aimed at edge-AI workloads such as sensor fusion, autonomous systems, and machine-learning inference. Its product line spans custom servers, data-acquisition chassis, GPU-accelerated compute modules, solid-state storage arrays, and hardened industrial PCs, tablets, and handhelds that meet MIL-SPEC environmental standards.
According to the company’s FY 2023 Form 10-K, OSS generated **$71.5 million** in revenue, representing a **~12 % year-over-year increase** driven primarily by higher sales to defense contractors and multinational technology firms. Gross margin improved to **38 %** from 34 % the prior year, reflecting a shift toward higher-margin GPU-based systems and a reduction in component-cost volatility.
Key sector drivers include the **edge-AI market**, which IDC forecasts to grow at a **22 % CAGR through 2028**, and **U.S. defense spending**, projected to rise 3–4 % annually, both of which underpin demand for rugged, low-latency compute solutions. OSS’s **backlog of roughly $45 million** (as of Q4 2023) suggests a pipeline that could sustain double-digit top-line growth if supply-chain constraints remain manageable.
The company sells primarily through a direct sales force, OEM partnerships, and a network of resellers, targeting multinational corporations, government agencies, and military customers. Its cash-and-equivalents position of **$15 million** at year-end provides a modest liquidity buffer, but the firm’s capital-intensive R&D model implies a need for continued cash flow generation or external financing.
For a quick, data-driven comparison of OSS’s valuation multiples against peers, see ValueRay’s OSS overview page.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -6.91m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.18 > 0.02 and ΔFCF/TA -19.58 > 1.0 |
| NWC/Revenue: 38.39% < 20% (prev 50.61%; Δ -12.22% < -1%) |
| CFO/TA -0.17 > 3% & CFO -7.18m > Net Income -6.91m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.8m) vs 12m ago 8.51% < -2% |
| Gross Margin: 29.01% > 18% (prev 0.19%; Δ 2882 % > 0.5%) |
| Asset Turnover: 139.0% > 50% (prev 120.7%; Δ 18.28% > 0%) |
| Interest Coverage Ratio: -132.3 > 6 (EBITDA TTM -4.95m / Interest Expense TTM 46.1k) |
Altman Z'' -0.94
| A: 0.54 (Total Current Assets 36.0m - Total Current Liabilities 12.9m) / Total Assets 43.1m |
| B: -0.60 (Retained Earnings -25.8m / Total Assets 43.1m) |
| C: -0.14 (EBIT TTM -6.11m / Avg Total Assets 43.4m) |
| D: -1.49 (Book Value of Equity -24.8m / Total Liabilities 16.7m) |
| Altman-Z'' Score: -0.94 = CCC |
Beneish M -3.28
| DSRI: 1.13 (Receivables 12.0m/9.33m, Revenue 60.3m/52.7m) |
| GMI: 0.64 (GM 29.01% / 18.54%) |
| AQI: 0.76 (AQ_t 0.04 / AQ_t-1 0.05) |
| SGI: 1.14 (Revenue 60.3m / 52.7m) |
| TATA: 0.01 (NI -6.91m - CFO -7.18m) / TA 43.1m) |
| Beneish M-Score: -3.28 (Cap -4..+1) = AA |
What is the price of OSS shares?
Over the past week, the price has changed by -6.57%, over one month by +43.48%, over three months by +73.03% and over the past year by +123.73%.
Is OSS a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OSS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9 | -2.6% |
| Analysts Target Price | 9 | -2.6% |
| ValueRay Target Price | 9.5 | 2.9% |
OSS Fundamental Data Overview February 03, 2026
P/S = 4.0233
P/B = 9.8845
Revenue TTM = 60.3m USD
EBIT TTM = -6.11m USD
EBITDA TTM = -4.95m USD
Long Term Debt = 4.33m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.69m USD (from shortTermDebt, last quarter)
Debt = 6.50m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -8880 USD (from netDebt column, last quarter)
Enterprise Value = 242.4m USD (242.5m + Debt 6.50m - CCE 6.51m)
Interest Coverage Ratio = -132.3 (Ebit TTM -6.11m / Interest Expense TTM 46.1k)
EV/FCF = -31.45x (Enterprise Value 242.4m / FCF TTM -7.71m)
FCF Yield = -3.18% (FCF TTM -7.71m / Enterprise Value 242.4m)
FCF Margin = -12.79% (FCF TTM -7.71m / Revenue TTM 60.3m)
Net Margin = -11.47% (Net Income TTM -6.91m / Revenue TTM 60.3m)
Gross Margin = 29.01% ((Revenue TTM 60.3m - Cost of Revenue TTM 42.8m) / Revenue TTM)
Gross Margin QoQ = 35.68% (prev 31.27%)
Tobins Q-Ratio = 5.63 (Enterprise Value 242.4m / Total Assets 43.1m)
Interest Expense / Debt = 0.23% (Interest Expense 15.1k / Debt 6.50m)
Taxrate = 21.0% (US default 21%)
NOPAT = -4.82m (EBIT -6.11m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.80 (Total Current Assets 36.0m / Total Current Liabilities 12.9m)
Debt / Equity = 0.25 (Debt 6.50m / totalStockholderEquity, last quarter 26.3m)
Debt / EBITDA = 0.00 (negative EBITDA) (Net Debt -8880 / EBITDA -4.95m)
Debt / FCF = 0.00 (negative FCF - burning cash) (Net Debt -8880 / FCF TTM -7.71m)
Total Stockholder Equity = 26.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -15.93% (Net Income -6.91m / Total Assets 43.1m)
RoE = -26.13% (Net Income TTM -6.91m / Total Stockholder Equity 26.4m)
RoCE = -19.85% (EBIT -6.11m / Capital Employed (Equity 26.4m + L.T.Debt 4.33m))
RoIC = -17.35% (negative operating profit) (NOPAT -4.82m / Invested Capital 27.8m)
WACC = 10.88% (E(242.5m)/V(249.0m) * Re(11.17%) + D(6.50m)/V(249.0m) * Rd(0.23%) * (1-Tc(0.21)))
Discount Rate = 11.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.22%
Fair Price DCF = unknown (Cash Flow -7.71m)
EPS Correlation: -31.05 | EPS CAGR: -3.98% | SUE: -0.43 | # QB: 0
Revenue Correlation: -55.12 | Revenue CAGR: 1.44% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=-0.020 | Revisions Net=-2 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.01 | Chg30d=-0.080 | Revisions Net=-1 | Growth EPS=+100.0% | Growth Revenue=+19.8%